leadf
logo-loader
viewNovavax, Inc.

Novavax expands late-stage UK trial for COVID-19 vaccine candidate to 15,000 volunteers

So far the firm has enrolled 5,500 participants to date and expects to complete the recruitment by the end of November

Novavax, Inc. - Novavax expands late-stage UK trial for COVID-19 vaccine candidate to 15,000 volunteers

Novavax Inc (NASDAQ:NVAX) announced it has expanded the phase 3 of its COVID-19 vaccine candidate to 15,000 volunteers in the UK.

The US pharma company said increasing the number of participants will shorten the process.

READ: The runners in the COVID-19 vaccine race

So far it has enrolled 5,500 participants to date and expects to complete the recruitment by the end of November.

Depending on the overall infection rate in the country, interim data are expected early in the first quarter 2021.

Meanwhile, the phase 3 of trials in the US and Mexico is planned to begin by end of November, involving up to 30,000 participants across the two countries, with proportional representation among diverse populations most vulnerable to COVID-19 distributed across race/ethnicity, age and those living with co-morbidities.

The firm said it has made significant progress in large-scale manufacturing but experienced delays in meeting the original timeline.

Novavax is due to present data from its ongoing Phase 1/2 clinical trial, including new Phase 2 reactogenicity data, on October 30 in the US.

‘Reactogenicity’ indicates the common, expected adverse effects produced by a vaccine during clinical trials, such as fever and sore arm.

Shares shot up 6% to US$92.55 when the market opened on Tuesday.

Quick facts: Novavax, Inc.

Price: 125.69 USD

NASDAQ:NVAX
Market: NASDAQ
Market Cap: $8 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

FansUnite Entertainment pleased Canada taking a look at allowing single...

FansUnite Entertainment (CSE: FANS- OTCQB: FUNFF) President Darius Eghdami joined Steve Darling from Proactive with news the company is hailing the Canadian government’s decision to introduce legislation that would legalize single-event sports betting in Canada. Eghdami talks about why that...

1 day, 21 hours ago

2 min read